Luxembourg, Mai 01, 2017
BSN medical, the global integrated medical therapy provider, will display and discuss its Advanced Wound Care ranges and supporting Compression Therapy, including bandages and hosiery portfolios, at the renowned EWMA 2017 Conference, in Amsterdam, The Netherlands, between May 3 and May 5, 2017.
BSN is a global full-service provider in Wound Care, dedicated to preventing and combating wound issues across the continuum of care. It offers a full range of products in the fields of Acute Wound Care, Advanced Wound Care, Lymphoedema and Vascular, through its Cutimed® and JOBST® brands.
BSN will be hosting a number of events and demonstrations at booth 3B02. There, delegates at the conference will learn more about BSN medical’s range of treatment options and its complete selection of effective, patient- and user-friendly products.
Luxembourg, April 03, 2017
SCA’s acquisition of BSN medical, a leading medical solutions company, has been closed.
The purchase price for the shares amounts to EUR 1,400m and takeover of net debt to approximately EUR 1,340m1). SCA consolidates BSN medical as of April 3, 2017.
SCA is a leading global hygiene and forest products company that sustainably develops, produces, markets and sells personal care, tissue and forest products. Sales are conducted in about 100 countries under many strong brands, including the leading global brands TENA and Tork, and regional brands, such as Libero, Libresse, Lotus, Nosotras, Saba, Tempo, Vinda and Zewa.
As Europe’s largest private forest owner, SCA places considerable emphasis on sustainable forest management. The Group has about 46,000 employees. Sales in 2016 amounted to approximately SEK 117bn (EUR 12.4bn). SCA was founded in 1929, has its headquarters in Stockholm, Sweden, and is listed on NASDAQ Stockholm. More information at www.sca.com.
Luxembourg, March 14, 2017
CHARLOTTE, N.C., March 14, 2017 – BSN medical, the global integrated medical therapy provider, announced today that Yogendra M. Kanthi, M.D., a cardiologist and vascular medicine specialist at the University of Michigan, is the 2017 recipient of the BSN-JOBST $100,000 Research Grant. BSN has contributed to important independent research in venous and lymphatic diseases through this grant for the past 21 years.
In 1995, BSN, in association with the American Venous Forum (AVF), initiated the research grant to further Conrad Jobst’s legacy of innovation. The Fellowship, which has helped to jump-start the careers of young investigators, is designed to provide a foundation of research to build on future work and grants for mentored and independent research. Recipients are asked to submit a one-year update and present a progress report to the AVF membership at its Annual Meeting. BSN increased the research grant from $50,000 to $100,000 in 2015.
Luxembourg, December 19, 2016
CHARLOTTE, N.C., October 19, 2016
BSN medical, the global integrated medical therapy solutions provider, announced today the launch of JOBST® Relax, a custom-knit compression garment that redefines the nighttime management of lymphedema.
This new alternative to bandaging provides the containment lymphedema patients need in a sleek design that is clinically effective, while also aesthetically pleasing. JOBST Relax is designed to be worn during rest and relaxation, in addition to sleeping, giving patients the freedom to enjoy leisure activities while remaining compliant.
Luxembourg/Hamburg, August 18, 2016
BSN and NASA Collaborate Exclusively on Solution for Orthostatic Intolerance Following Long-Duration Spaceflight
BSN medical, the global integrated medical therapy solutions provider, announced an ongoing collaboration with NASA to develop a specialized gradient compression garment for protection against post-spaceflight orthostatic intolerance – the inability to stand upright without experiencing a rapid heart rate, low blood pressure (hypotension), lightheadedness or feeling faint upon return to Earth’s gravity.
Luxembourg, May 13, 2016
BSN medical, a global integrated medical solutions provider, has marked its 15 year anniversary by posting healthy revenue growth in 2015, and further increasing its global reach. Supported by strong organic growth, positive currency effects and targeted acquisitions, revenues grew by 12.9% to €861 million, with sales growth in all of BSN’s market. Alongside ongoing high levels of investment in R&D, new products and targeted acquisitions, BSN’s profitability increased in 2015.
Luxembourg/Bogotá, December 16, 2015
BSN medical and Ortopédicos Futuro announce today a joint venture agreement to strengthen their market position in compression garments in Colombia, Ecuador and neighbouring markets. In their joint effort, BSN and Ortopédicos Futuro will push for national and international expansion. As part of the collaboration, BSN provides a relevant product portfolio as well as capabilities and resources. Ortopédicos Futuro contributes its No-Varix® compression garments assortment and customer proximity through their 23 shops in Colombia and Ecuador.
Hamburg, Germany November 24, 2015
BSN medical announces the acquisition of Wright Therapy Products, Inc., a leading manufacturer of compression therapy systems, to become a full solution provider of lymphoedema care products and expand its portfolio of solutions used to treat chronic venous insufficiency. This latest acquisition aligns with BSN’s recent purchases of FarrowMed and JoViPak to fortify the therapeutic solutions offered to patients while strengthening its wound care and vascular franchise.
Hamburg, Germany September 7, 2015
BSN medical continues to strengthen its position as a market-leading provider of lymphoedema therapy solutions with the purchase of JoViPak®, a manufacturer of lymphoedema garments. This acquisition complements BSN’s comprehensive product portfolio designed for the management of lymphatic disorders and allows the company to cater to the underserved yet rapidly growing market of lymphoedema management during the day and nighttime.
BSN’s acquisition of JoViPak is an attractive complement to the recently announced acquisition of FarrowMed, which provides BSN with the patented FarrowWrap® compression wrap used to manage lymphoedema.
Hamburg, Germany September 7, 2015
BSN medical continues to strengthen its position as a market-leading provider of lymphoedema therapy solutions with the purchase of JoViPak®, a manufacturer of lymphoedema garments. This acquisition complements BSN’s comprehensive product portfolio designed for the management of lymphatic disorders and allows the company to cater to the underserved yet rapidly growing market of lymphoedema management during the day and nighttime. BSN’s acquisition of JoViPak is an attractive complement to the recently announced acquisition of FarrowMed, which provides BSN with the patented FarrowWrap® compression wrap used to manage lymphoedema.
Hamburg, Germany June 29, 2015
BSN medical continues to strengthen its position as a market leading provider of lymphoedema therapy solutions by acquiring FarrowMed and its range of patented FarrowWrap® and related compression garment technologies, which focus on the management of lymphoedema and venous disease. The acquisition further enhances BSN medical’s comprehensive product portfolio for the management of lymphatic and venous disorders under the JOBST® and Elvarex® brands.
Hamburg/Tokyo, 31 March 2015
Today BSN medical and Terumo Corporation have announced a revised joint venture agreement that will further strengthen their joint position in the Japanese market. The Joint Venture will tap into the significant growth potential for BSN medical's Advanced Wound Care business, and will provide Terumo with long-term access to BSN medical's impressive product range. The joint venture will see a significant rise in revenue as the result of increased sales force activities alongside a new dedicated JV sales promotion team. These will leverage the strength of Terumo's existing sales force of 200 in the Japanese market.
Hamburg, 27 November 2014
BSN medical has taken another significant step to strengthen its portfolio in the highly attractive Wound Care market by acquiring Sorbion, a specialised technology company, focussing on products for the treatment of chronic wounds. This acquisition complements BSN’s recent launch of the Negative Pressure Wound Therapy (NPWT) system, Cura Sul®. Both steps broaden BSN’s complete offering to patients suffering from acute and chronic wounds, and further improve its position among the leading companies in Wound Care.